
NeuroMetrix NURO
Geschäftsbericht 2024
hinzugefügt 31.03.2025
NeuroMetrix Langfristige Verbindlichkeiten 2011-2026 | NURO
Langfristige Verbindlichkeiten Jährlich NeuroMetrix
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 917 K | - | - | 4.64 K | 280 K | 5.32 M | 1.95 M | 71.4 K | 119 K |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 5.32 M | 4.64 K | 1.24 M |
Langfristige Verbindlichkeiten anderer Aktien in der Medizinische Instrumente
| Name | Langfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
12.9 M | - | - | $ 810 M | ||
|
iRhythm Technologies
IRTC
|
119 M | $ 126.69 | 3.55 % | $ 4.05 B | ||
|
Repro Med Systems
KRMD
|
239 K | $ 4.04 | 2.02 % | $ 187 M | ||
|
Microbot Medical
MBOT
|
760 K | $ 2.17 | -1.36 % | $ 99.4 M | ||
|
Luminex Corporation
LMNX
|
205 M | - | - | $ 1.75 B | ||
|
Alcon
ALC
|
6.05 B | $ 75.98 | 0.26 % | $ 40.4 B | ||
|
Ekso Bionics Holdings
EKSO
|
11.2 M | $ 11.09 | -0.81 % | $ 26.9 M | ||
|
STERIS plc
STE
|
1.53 B | $ 222.41 | 0.28 % | $ 21.9 B | ||
|
The Cooper Companies
COO
|
1.54 B | $ 64.35 | -0.11 % | $ 12.8 B | ||
|
Teleflex Incorporated
TFX
|
2.77 B | $ 136.1 | -0.34 % | $ 6.07 B | ||
|
Antares Pharma, Inc.
ATRS
|
30.2 M | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
1.16 B | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
74.1 M | - | - | $ 282 M | ||
|
Hill-Rom Holdings, Inc.
HRC
|
1.99 B | - | -0.05 % | $ 10.3 B | ||
|
Milestone Scientific
MLSS
|
1.4 M | $ 0.33 | 2.64 % | $ 27.1 M | ||
|
Varian Medical Systems, Inc.
VAR
|
421 M | - | -0.02 % | $ 16.3 B | ||
|
Utah Medical Products
UTMD
|
5.25 M | $ 66.54 | -0.93 % | $ 216 M | ||
|
Haemonetics Corporation
HAE
|
405 M | $ 60.1 | 0.28 % | $ 3.02 B | ||
|
electroCore
ECOR
|
1.42 M | $ 6.11 | -1.05 % | $ 51.8 K | ||
|
ICU Medical
ICUI
|
66.7 M | $ 122.07 | -2.2 % | $ 3.01 B | ||
|
Envista Holdings Corporation
NVST
|
1.91 B | $ 26.85 | 0.22 % | $ 4.51 B | ||
|
Isoray
ISR
|
621 K | - | 0.03 % | $ 108 M | ||
|
Intuitive Surgical
ISRG
|
418 M | $ 470.68 | -2.39 % | $ 168 B | ||
|
Glaukos Corporation
GKOS
|
87.4 M | $ 121.0 | -0.54 % | $ 5.86 B | ||
|
Masimo Corporation
MASI
|
56 M | $ 178.57 | -0.03 % | $ 9.52 B | ||
|
InfuSystem Holdings
INFU
|
35 M | $ 10.68 | 3.29 % | $ 221 M | ||
|
Merit Medical Systems
MMSI
|
626 M | $ 67.12 | -2.13 % | $ 3.97 B | ||
|
West Pharmaceutical Services
WST
|
427 M | $ 301.99 | -1.27 % | $ 21.8 B | ||
|
Pulse Biosciences
PLSE
|
6.72 M | $ 22.54 | -2.11 % | $ 1.52 B | ||
|
DENTSPLY SIRONA
XRAY
|
2.54 B | $ 11.96 | 0.38 % | $ 2.38 B | ||
|
Retractable Technologies
RVP
|
2.38 M | $ 0.63 | -3.08 % | $ 18.9 M | ||
|
Pro-Dex
PDEX
|
9.93 M | $ 51.23 | -1.67 % | $ 168 M | ||
|
LeMaitre Vascular
LMAT
|
19.3 M | $ 114.42 | 0.86 % | $ 2.59 B | ||
|
Predictive Oncology
POAI
|
236 K | - | - | $ 31.1 M | ||
|
STAAR Surgical Company
STAA
|
12.5 M | $ 26.56 | 3.45 % | $ 1.32 B | ||
|
BioLife Solutions
BLFS
|
41.7 M | $ 21.32 | -0.28 % | $ 982 M | ||
|
Stereotaxis
STXS
|
1.65 M | $ 1.95 | 0.78 % | $ 177 M | ||
|
Baxter International
BAX
|
7.05 B | $ 18.52 | 2.04 % | $ 9.5 B | ||
|
ResMed
RMD
|
1.05 B | $ 223.2 | 1.52 % | $ 32.6 B | ||
|
AtriCure
ATRC
|
261 M | $ 29.05 | -0.79 % | $ 1.39 B | ||
|
Harvard Bioscience
HBIO
|
58.5 M | $ 6.9 | 0.58 % | $ 306 M | ||
|
AngioDynamics
ANGO
|
148 M | $ 10.99 | -0.99 % | $ 449 M | ||
|
Becton, Dickinson and Company
BDX
|
25 B | $ 150.44 | -1.11 % | $ 43.3 B | ||
|
Nephros
NEPH
|
1.61 M | $ 3.0 | 4.53 % | $ 31.2 M | ||
|
OraSure Technologies
OSUR
|
22.5 M | $ 2.99 | -0.5 % | $ 220 M | ||
|
Repligen Corporation
RGEN
|
701 M | $ 119.05 | 1.23 % | $ 6.63 M |